Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM)

被引:0
作者
Matthias Totzeck
Nicolas Aide
Johann Bauersachs
Jan Bucerius
Panagiotis Georgoulias
Ken Herrmann
Fabien Hyafil
Jolanta Kunikowska
Mark Lubberink
Carmela Nappi
Tienush Rassaf
Antti Saraste
Roberto Sciagra
Riemer H. J. A. Slart
Hein Verberne
Christoph Rischpler
机构
[1] University Hospital Essen,Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen
[2] University Duisburg-Essen,Nuclear Medicine Department
[3] University Hospital,Department of Nuclear Medicine
[4] Department of Cardiology and Angiology,Department of Nuclear Medicine, Faculty of Medicine
[5] Hannover Medical School,Clinic for Nuclear Medicine
[6] University Medicine Göttingen,Department of Nuclear Medicine
[7] Georg-August-University Göttingen,Nuclear Medicine Department
[8] University of Thessaly,Medical Physics
[9] University Hospital of Larissa,Department of Advanced Biomedical Sciences
[10] University Hospital Essen,Heart Center
[11] University of Duisburg-Essen,Nuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”
[12] DMU IMAGINA,Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging
[13] Georges-Pompidou European Hospital,Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location AMC
[14] Assistance-Publique – Hôpitaux de Paris,undefined
[15] University of Paris,undefined
[16] Medical University of Warsaw,undefined
[17] Uppsala University Hospital,undefined
[18] University of Naples “Federico II”,undefined
[19] Turku University Hospital and University of Turku,undefined
[20] University of Florence,undefined
[21] University of Groningen,undefined
[22] University Medical Center Groningen,undefined
[23] Department of Biomedical Photonic Imaging,undefined
[24] Faculty of Science and Technology,undefined
[25] University of Amsterdam,undefined
来源
European Journal of Nuclear Medicine and Molecular Imaging | 2023年 / 50卷
关键词
Nuclear medicine; Cancer therapy-related cardiotoxicity; Cardio-oncology; PET; SPECT; Chemotherapy; Radiotherapy; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:792 / 812
页数:20
相关论文
共 605 条
  • [21] Lin Y(2017)Cardio-oncology: the nuclear option Curr Cardiol Rep 19 31-135
  • [22] Herrmann J(2018)Diagnosis, treatment, and prevention of cardiovascular toxicity related to anti-cancer treatment in clinical practice: an opinion paper from the working group on cardio-oncology of the Korean Society of Echocardiography J Cardiovasc Ultrasound 26 1-1549
  • [23] Rassaf T(2017)Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1 J Am Coll Cardiol 70 2536-1314
  • [24] Totzeck M(2020)SNMMI procedure standard/EANM guideline for gated equilibrium radionuclide angiography J Nucl Med Technol 48 126-884
  • [25] Schuler M(2019)Left ventricular ejection fraction determined with the simulation of a very low-dose CZT-SPECT protocol and an additional count-calibration on planar radionuclide angiographic data J Nucl Cardiol 26 1539-518
  • [26] Stuschke M(2021)Equilibrium radionuclide angiography: intra- and inter-observer repeatability and reproducibility in the assessment of cardiac systolic and diastolic function J Nucl Cardiol 28 1304-1940
  • [27] Heusch G(2016)The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy J Nucl Cardiol 23 856-157
  • [28] Rassaf T(2020)Nuclear cardio-oncology: from its foundation to its future J Nucl Cardiol 27 511-348
  • [29] Michel L(2015)EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision Eur J Nucl Med Mol Imaging 42 1929-213
  • [30] Rassaf T(2005)Cardiovascular risk assessment in cancer patients undergoing major surgery J Nucl Cardiol 12 151-1850